Evidence for Proinflammatory β-1,6 Glucans in the Pneumocystis carinii Cell Wall

Area of Science:

• Immunology
• Mycology
• Cell Biology

Background:

• Inflammation significantly impairs respiratory function in Pneumocystis pneumonia.
• Fungal cell wall beta-glucans are key stimulators of inflammatory responses.
• While beta-1,3 glucans in Pneumocystis have been studied, the role of beta-1,6 glucans in host activation is less understood.

Purpose of the Study:

• To characterize beta-1,6 glucans in the Pneumocystis cell wall.
• To investigate the role of beta-1,6 glucans in activating lung cell inflammation.

Main Methods:

• Immune staining to identify beta-1,6 glucan localization in P. carinii.
• Cloning and functional characterization of a P. carinii beta-1,6 glucan synthase (Pckre6).
• Assessing the impact of beta-1,6 glucan synthase inhibitors on P. carinii preparations.
• Evaluating inflammatory responses of macrophages to isolated Pneumocystis beta-1,6 glucan fractions.
• Investigating the effect of host cell plasma membrane microdomain inhibition on inflammatory responses.

Main Results:

• Specific localization of beta-1,6 glucans was observed in P. carinii cyst walls.
• A functional P. carinii beta-1,6 glucan synthase (Pckre6) was identified and characterized.
• Inhibitors of beta-1,6 glucan synthesis reduced beta-1,6 carbohydrate production by P. carinii.
• Isolated Pneumocystis beta-1,6 glucans induced significant tumor necrosis factor alpha (TNF-α) release from macrophages.
• Inhibition of host cell microdomain function markedly reduced these inflammatory responses.

Conclusions:

• Beta-1,6 glucans are integral components of the P. carinii cell wall.
• These beta-1,6 glucans actively contribute to lung cell inflammatory activation during Pneumocystis pneumonia.
• Targeting beta-1,6 glucan synthesis or host cell interactions presents a potential therapeutic strategy.